β

Biomarkers, Tumor / biosynthesis Case-Control Studies Colorectal Neoplasms / blood Humans Integrin beta Chains / biosynthesis Prognosis Proof of Concept Study Proportional Hazards Models RNA, Messenger / biosynthesis Reproducibility of Results
ITGB6 colorectal cancer metastasis serum tumor marker surveillance therapy response

Journal

International journal of cancer
ISSN: 1097-0215
Titre abrégé: Int J Cancer
Pays: United States
ID NLM: 0042124

Informations de publication

Date de publication:
01 08 2019
Historique:
received: 30 05 2018
revised: 14 11 2018
accepted: 19 12 2018
pubmed: 18 1 2019
medline: 18 12 2019
entrez: 18 1 2019
Statut: ppublish

Résumé

Colorectal cancer (CRC) is one of the leading causes of cancer-related deaths worldwide and the need for novel biomarkers and therapeutic strategies to improve diagnosis and surveillance is obvious. This study aims to identify β

Identifiants

DOI: 10.1002/ijc.32137 PMID: 30653264
pubmed: 30653264
doi: 10.1002/ijc.32137
doi:

Substances chimiques

Biomarkers, Tumor 0
Integrin beta Chains 0
RNA, Messenger 0
integrin beta6 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

678-685

Subventions

Organisme : Medical Research Council
ID : G0901226
Pays : United Kingdom

Informations de copyright

© 2019 UICC.

Auteurs

Susan Bengs (S)

Department of Gastroenterology and Hepatology, University Hospital Zurich, Zurich, Switzerland.

Eugenia Becker (E)

Department of Gastroenterology and Hepatology, University Hospital Zurich, Zurich, Switzerland.

Philipp Busenhart (P)

Department of Gastroenterology and Hepatology, University Hospital Zurich, Zurich, Switzerland.

Marianne R Spalinger (MR)

Department of Gastroenterology and Hepatology, University Hospital Zurich, Zurich, Switzerland.

Tina Raselli (T)

Department of Gastroenterology and Hepatology, University Hospital Zurich, Zurich, Switzerland.

Stephanie Kasper (S)

Department of Gastroenterology and Hepatology, University Hospital Zurich, Zurich, Switzerland.

Silvia Lang (S)

Department of Gastroenterology and Hepatology, University Hospital Zurich, Zurich, Switzerland.

Kirstin Atrott (K)

Department of Gastroenterology and Hepatology, University Hospital Zurich, Zurich, Switzerland.

Celine Mamie (C)

Department of Gastroenterology and Hepatology, University Hospital Zurich, Zurich, Switzerland.

Stephan R Vavricka (SR)

Department of Gastroenterology and Hepatology, University Hospital Zurich, Zurich, Switzerland.

Lotta von Boehmer (L)

Department of Immunology, Stanford University, Stanford, CA.

Alexander Knuth (A)

National Center for Cancer Care and Research NCCCR, Hamad Medical Corporation, Doha, Qatar.

Anne Tuomisto (A)

Cancer and Translational Medicine Research Unit, Department of Pathology, University of Oulu, Oulu, Finland.
Oulu University Hospital and Medical Research Center Oulu, Oulu, Finland.
ORCID: 0000-0002-9949-1887

Markus J Mäkinen (MJ)

Cancer and Translational Medicine Research Unit, Department of Pathology, University of Oulu, Oulu, Finland.
Oulu University Hospital and Medical Research Center Oulu, Oulu, Finland.

Petr Hruz (P)

Department of Gastroenterology, University Hospital, Basel, Switzerland.

Matthias Turina (M)

Department of Visceral and Transplant Surgery, University and University Hospital Zurich, Zürich, Switzerland.

Andreas Rickenbacher (A)

Department of Visceral and Transplant Surgery, University and University Hospital Zurich, Zürich, Switzerland.

Henrik Petrowsky (H)

Department of Visceral and Transplant Surgery, University and University Hospital Zurich, Zürich, Switzerland.

Achim Weber (A)

Department of Pathology, Institute of Surgical Pathology, University Hospital Zurich, Zurich, Switzerland.

Pascal Frei (P)

Clinic for Gastroenterology Bethanien, Zürich, Switzerland.

Marcel Halama (M)

Clinic for Gastroenterology Zurich-Fluntern, Zurich, Switzerland.

Gisli Jenkins (G)

Faculty of Medicine and Health Sciences, University of Nottingham, Nottingham, United Kingdom.

Dean Sheppard (D)

Division of Pulmonary, Critical Care, Allergy and Sleep Medicine, Department of Medicine, University of California, San Francisco, CA.

Roland S Croner (RS)

Department of Surgery, University Hospital Magdeburg, Magdeburg, Germany.

Jan Christoph (J)

Department of Medical Informatics, University of Erlangen-Nuremberg, Erlangen, Germany.

Nathalie Britzen-Laurent (N)

Division of Molecular and Experimental Surgery, University Medical Center Erlangen, Erlangen, Germany.

Elisabeth Naschberger (E)

Division of Molecular and Experimental Surgery, University Medical Center Erlangen, Erlangen, Germany.

Vera Schellerer (V)

Division of Molecular and Experimental Surgery, University Medical Center Erlangen, Erlangen, Germany.

Michael Stürzl (M)

Division of Molecular and Experimental Surgery, University Medical Center Erlangen, Erlangen, Germany.

Michael Fried (M)

Department of Gastroenterology and Hepatology, University Hospital Zurich, Zurich, Switzerland.

Gerhard Rogler (G)

Department of Gastroenterology and Hepatology, University Hospital Zurich, Zurich, Switzerland.
Zurich Center for Integrative Human Physiology, University of Zurich, Zurich, Switzerland.

Michael Scharl (M)

Department of Gastroenterology and Hepatology, University Hospital Zurich, Zurich, Switzerland.
Zurich Center for Integrative Human Physiology, University of Zurich, Zurich, Switzerland.
ORCID: 0000-0002-6729-1469

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Facteurs biologiques › Marqueurs biologiques › Marqueurs biologiques tumoraux › β
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Caractéristiques des études épidémiologiques › Études épidémiologiques › Études cas-témoins › β
questionsmedicales.fr › Maladies de l'appareil digestif › Maladies gastro-intestinales › Maladies intestinales › Maladies du rectum › Tumeurs colorectales › β
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › β
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Protéines membranaires › Récepteurs de surface cellulaire › Récepteurs immunologiques › Intégrines › Chaines bêta des intégrines › β
questionsmedicales.fr › Diagnostic › Pronostic › β
questionsmedicales.fr › Disciplines des sciences naturelles › Science › Recherche › Étude de validation de principe › β
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Statistiques comme sujet › Analyse de survie › Modèles des risques proportionnels › β
questionsmedicales.fr › Acides nucléiques, nucléotides et nucléosides › Acides nucléiques › ARN › ARN messager › β
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Méthodologie en recherche épidémiologique › Reproductibilité des résultats › β